Iboga in the United States · LA
Iboga and ibogaine in Louisiana
Louisiana SB 43 creates a Psychedelic-Assisted Therapy Initiative covering ibogaine at the Department of Health; effective 2026-08-01.
Status
Law enacted
—
State research funding
1
Bills tracked
October 26, 2026
Last checked
Where Louisiana stands
SB 43 (Sen. Pat McMath), now Act 956 of 2026, creates a Psychedelic-Assisted Therapy Initiative in the Department of Health's Office of Behavioral Health. The initiative identifies academic health centers studying ibogaine, MDMA, psilocybin and related compounds for opioid use disorder, co-occurring substance use disorders and treatment-resistant neurological or mental health conditions, and designates a state point of contact to coordinate with federal agencies and other states. An academic health center may form a consortium with a drug developer to run ibogaine drug-development trials and may partner with another state's consortium; the state keeps a royalty of at least 2.5 percent of net sales on resulting products. Centers coordinate with parishes using opioid settlement funds to enroll eligible residents, report to the department by January 1 each year, and the department reports to the legislature by March 1 each year. The bill passed the Senate 37-0 and the House 97-0 in May 2026, became law without the governor's signature on 2026-06-23, and took effect 2026-08-01.
A law touching ibogaine or iboga is on the books.
Funding: Act 956 carries no appropriation. Academic health centers coordinate with parishes using opioid settlement funds to enroll eligible residents, the department may accept federal funds, gifts and grants for the initiative, and the department is to encourage using settlement money as a match for federal or other outside funding.
Timeline
SB 43 becomes Act 956 without governor's signature
The Psychedelic-Assisted Therapy Initiative became law without Gov. Landry's signature and took effect 2026-08-01. Louisiana will take part in a national ibogaine research and drug-development consortium.
SB 43 passes both chambers unanimously
Senate 37-0, House 97-0; sent to the governor. Covers ibogaine and psilocybin research pathways.
Source: WAFB
Bills
| Bill | Title | Status |
|---|---|---|
| SB 43 (Act 956 of 2026) | Psychedelic-Assisted Therapy Initiative | Became Act 956 without the governor's signature 2026-06-23; effective 2026-08-01 |
Who is involved
- Louisiana Department of Health, Office of Behavioral Health
Hosts the Psychedelic-Assisted Therapy Initiative.
Government agencies
For Louisiana residents: a whole root ceremony on Kauaʻi
Vital Kauaʻi is a legally established church on Kauaʻi’s North Shore. Members from Louisiana join a thirteen-week journey: six weeks of preparation from home, one week on the island with two held nights with the whole root in ceremony, and six weeks of integration after. Guides, a medical provider, somatic practitioners and integration coaches walk with each member through all of it.
Preparation, from Louisiana
A medical consultation and health review, somatic and nervous-system preparation, and weekly guidance through the member portal. All of it happens from home, on Zoom, before travel.
Ceremony, on Kauaʻi
Two nights with the whole root in nature, one-on-one or in a container of up to three, with experienced guides and the medical provider present overnight. An EKG on-island comes first.
Integration, back in Louisiana
Six weekly one-on-one calls with an integration coach, plus somatic sessions, so what the root shows you becomes how you live, lead and create at home.
Book a discovery callThirty minutes on Zoom. We meet you, and you share what is calling you.
In the news, video and podcasts
News, videos and podcasts that name Louisiana appear here as Iboga Worldwide gathers it, daily.
Every state
How this tracker is kept
- Each state is checked against legislature records, agency releases and published reporting, and carries the date it was last checked. Every development links to its source.
- “No known activity” means the state was checked on the date shown and no ibogaine-specific law, bill, funding or task force was found.
- The directory lists organizations and public offices with their own websites. Listing points readers to them and does not endorse them.
- This tracker is offered for education and does not constitute legal or medical advice. Ibogaine and iboga remain Schedule I substances under federal law. See the medical disclaimer.
- To share a development or request a correction, write to aloha@vitalkauai.com. For daily coverage, see Iboga Worldwide.